Inhibitors of mTOR

Inhibitors of mammalian target of rapamycin (mTOR) have been approved for the treatment of renal cell carcinoma and appear to have a role in the treatment of other malignancies. The primary objective of this drug review is to provide pharmacokinetic and dynamic properties of the commonly used drugs...

Full description

Saved in:
Bibliographic Details
Main Authors: Klümpen, Heinz-Josef, Beijnen, Jos H., Gurney, Howard, Schellens, Jan H.M.
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2010
Subjects:
Clinical Pharmacology: Concise Drug Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227930/
https://ncbi.nlm.nih.gov/pubmed/21147869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0196
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items